^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    methylprednisolone oral

    Associations

    News

    Trials
    Company:
    Generic mfg.
    Drug class:
    GCR agonist
    Related drugs:
    Associations

    News

    Trials
    8d
    EASE-NMO: Eculizumab For the Acute Attack of Neuromyelitis Optica Spectrum Disorder (clinicaltrials.gov)
    P2, N=110, Active, not recruiting, Tianjin Medical University General Hospital | Recruiting --> Active, not recruiting | Trial completion date: Dec 2026 --> Sep 2026 | Trial primary completion date: Aug 2026 --> Apr 2026
    Enrollment closed • Trial completion date • Trial primary completion date
    |
    methylprednisolone oral
    16d
    Methylprednisolone Addition to Multimodal Pain Regimens After Anterior Cruciate Ligament Reconstruction (clinicaltrials.gov)
    P4, N=64, Not yet recruiting, University of Alabama at Birmingham
    New P4 trial
    |
    methylprednisolone oral
    29d
    Azithromycin in the Management of Patients With Acute Exacerbation of Idiopathic Pulmonary Fibrosis (clinicaltrials.gov)
    P=N/A, N=1000, Recruiting, Assiut University | N=30 --> 1000 | Trial completion date: May 2026 --> Feb 2027 | Trial primary completion date: May 2026 --> Jan 2027
    Enrollment change • Trial completion date • Trial primary completion date
    |
    methylprednisolone oral • methylprednisolone sodium succinate
    2ms
    Oral Steroid Taper After Total Knee Arthroplasty (clinicaltrials.gov)
    P1, N=116, Active, not recruiting, Columbia University | Recruiting --> Active, not recruiting | Trial primary completion date: Jun 2026 --> Dec 2025
    Enrollment closed • Trial primary completion date
    |
    methylprednisolone oral
    2ms
    Medrol Dosepak for Outpatient Total Knee Arthroplasty (clinicaltrials.gov)
    P4, N=420, Recruiting, Rush University Medical Center | Trial primary completion date: Mar 2026 --> May 2026
    Trial primary completion date
    |
    methylprednisolone oral
    2ms
    A Multicenter, Prospective, Randomized Controlled Study Comparing Glucocorticoid Combined With Sirolimus With Monotherapy of Glucocorticoid in the Treatment of Newly Diagnosed Mild Autoimmune Hemolytic Anemia (clinicaltrials.gov)
    P=N/A, N=216, Not yet recruiting, Chen Miao
    New trial
    |
    CD4 (CD4 Molecule)
    |
    sirolimus • methylprednisolone oral
    5ms
    Azithromycin in the Management of Patients With Acute Exacerbation of Idiopathic Pulmonary Fibrosis (clinicaltrials.gov)
    P=N/A, N=30, Recruiting, Assiut University | Trial completion date: Dec 2025 --> Apr 2026 | Trial primary completion date: Dec 2025 --> Mar 2026
    Trial completion date • Trial primary completion date
    |
    methylprednisolone oral • methylprednisolone sodium succinate
    5ms
    A Rare Case of Polyserositis With Elevated Serum Cancer Antigen (CA)-125 in Systemic Lupus Erythematosus: A Case Report of Pseudo-Pseudo Meigs Syndrome. (PubMed, Cureus)
    Her symptoms were well-controlled with prednisolone and hydroxychloroquine. She presented with a history of shortness of breath, diffuse abdominal pain, and abdominal distension...The patient was treated initially with furosemide without improvement. After confirming the diagnosis, methylprednisolone and oral prednisone were then administered with a favorable prognosis...Early recognition is crucial to minimize the need for unnecessary invasive procedures. The goal is to initiate the appropriate management as early as possible to optimize patient outcomes.
    Journal
    |
    MUC16 (Mucin 16, Cell Surface Associated)
    |
    prednisone • hydroxychloroquine • methylprednisolone oral
    6ms
    Idiopathic Multicentric Castleman Disease With Severe Eosinophilia and Diffuse Centrilobular Nodule-A Rare Case Report. (PubMed, Case Rep Hematol)
    The patient declined cytotoxic chemotherapy and was treated with oral methylprednisolone (40 mg/day), which was gradually tapered to 10 mg/day...This case highlights a rare presentation of iMCD with eosinophilia and pulmonary involvement, emphasizing the importance of early recognition and timely corticosteroid therapy. Our report adds to the limited data on iMCD with eosinophilia and may help inform future clinical management.
    Journal
    |
    IL6 (Interleukin 6) • TNFA (Tumor Necrosis Factor-Alpha) • CXCL8 (Chemokine (C-X-C motif) ligand 8) • IL1B (Interleukin 1, beta)
    |
    methylprednisolone oral
    7ms
    Azithromycin in the Management of Patients With Acute Exacerbation of Idiopathic Pulmonary Fibrosis (clinicaltrials.gov)
    P=N/A, N=30, Recruiting, Assiut University | Active, not recruiting --> Recruiting | Trial primary completion date: Sep 2025 --> Dec 2025
    Enrollment open • Trial primary completion date
    |
    methylprednisolone oral • methylprednisolone sodium succinate
    7ms
    Retinoic Acid plus Hydroxychloroquine Sulfate and Methylprednisolone in Patients with Erosive Oral Lichen Planus: A Randomized and Controlled Clinical Trial (ChiCTR2500108290)
    P4, N=146, Not yet recruiting, Shanghai Ninth People's Hospital， Shanghai JiaoTong University School of Medicine; Shanghai Ninth People's Hospital， Shanghai JiaoTong University
    New P4 trial
    |
    hydroxychloroquine • methylprednisolone oral
    9ms
    EASE-NMO: Eculizumab For the Acute Attack of Neuromyelitis Optica Spectrum Disorder (clinicaltrials.gov)
    P2, N=110, Recruiting, Tianjin Medical University General Hospital
    New P2 trial
    |
    methylprednisolone oral